The global renal insufficiency treatment market has demonstrated significant growth, achieving a market value of USD 13.24 Billion in 2023, and is projected to reach an impressive USD 35.28 Billion by 2033. This surge represents a robust compound annual growth rate (CAGR) of 10.3% during the forecast period from 2023 to 2033, a substantial improvement from the 5.8% CAGR recorded during the historical period of 2018 to 2022.
According to the Centers for Disease Control and Prevention (CDC), more than 37 million people in the United States have kidney disease, and over 700,000 Americans are living with kidney failure, also known as end-stage renal disease (ESRD). In addition, kidney disease is a leading cause of death worldwide, with over 1.2 million deaths attributed to the disease in 2020 alone.
The increasing prevalence of kidney diseases is expected to drive the growth of the renal insufficiency treatment market, which includes a range of treatments for kidney failure and other renal disorders. These treatments include hemodialysis, peritoneal dialysis, kidney transplant, and medication.
Technological advancements in renal insufficiency treatment are also expected to drive the growth of the market. For example, the development of more advanced hemodialysis machines and catheters has made the procedure safer and more comfortable for patients, while the development of automated peritoneal dialysis machines has made peritoneal dialysis more accessible and convenient for patients.
Key Takeaways from the Market Study:
- The global renal insufficiency treatment market is expected to grow with a 10.3% CAGR during 2023 to 2033.
- By end user, dialysis centres are expected to hold 45% of the market share in 2023 for Renal insufficiency treatment market.
- North America is expected to possess 48% market share for Renal insufficiency treatment market in 2023.
- Europe Renal insufficiency treatment market size is expected to possess 41% market share in 2023.
“An increasing prevalence of kidney diseases, a growing aging population, and technological advancements in renal insufficiency treatment.” states an FMI analyst
Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!
Competitive Landscape:
Key players in the renal insufficiency treatment are Nipro Corp., Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., Medtronic Plc, Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., Cantel Medical, Nikkiso Co., Ltd., JMS Co. Ltd., AstraZeneca
- Nipro Corporation produces a range of peritoneal dialysis products, including the CAPD sets and cycler machines for automated peritoneal dialysis.
- Fresenius Medical Care produces a range of dialysis machines, dialyzers, bloodlines, and other equipment and supplies for use in hemodialysis and peritoneal dialysis treatment.
Key Segments Profiled in the Renal Insufficiency Treatment Industry Survey:
Treatment Type:
- Dialysis
- Medication
- Kidney Transplantation
End User:
- Dialysis Centres
- Hospital & Clinics
- Research & Academic Institutes
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube